Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of LP82 to treat hematopoietic disorders

Use of LP82 to treat hematopoietic disorders

US Patent 7101539 · Granted Sep 5, 2006

Estimated economic value: $72,797,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-tumor platinum-based drug mineralized protein nanoparticle, preparation met2025
Drugs for prevention or treatment of sepsis2025
Methods and compositions for synthesis of two-photon cleavable phosphoramidite m2024
Bi-specific anti-CGRP receptor/PAC1 receptor antigen binding proteins and uses t2024
MET antibody drug conjugates2021
Bi-specific anti-CGRP receptor/PAC1 receptor antigen binding proteins and uses t2021
PDE4 inhibitor2020
Therapeutic uses for VEGFR1 antibodies2017
VEGFR2/Ang2 compounds2017
Multifunctional antibodies binding to EGFR and MET2016
Anti-c-met antibodies2016
Anti-c-Met antibodies2015